Abstract
Purpose
Stomach adenocarcinoma represents a major health problem and is regarded as the second commonest cause of cancer-associated mortality, universally, since it is still difficult to be perceived at a curable stage. Several lines of evidence have pointed out that the expression of l-Dopa decarboxylase (DDC) gene and/or protein becomes distinctively modulated in several human neuroendocrine neoplasms as well as adenocarcinomas.
Methods
In order to elucidate the clinical role of DDC on primary gastric adenocarcinomas, we determined qualitatively and quantitatively the mRNA levels of the gene with regular PCR and real-time PCR by using the comparative threshold cycle method, correspondingly, and detected the expression of DDC protein by immunoblotting in cancerous and normal stomach tissue specimens.
Results
A statistically significant association was disclosed between DDC expression and gastric intestinal histotype as well as tumor localization at the distal third part of the stomach (p = 0.025 and p = 0.029, respectively). Univariate and multivariate analyses highlighted the powerful prognostic importance of DDC in relation to disease-free survival and overall survival of gastric cancer patients. According to Kaplan–Meier curves, the relative risk of relapse was found to be decreased in DDC-positive (p = 0.031) patients who, also, exhibited higher overall survival rates (p = 0.016) than those with DDC-negative tumors.
Conclusions
This work is the first to shed light on the potential clinical usefulness of DDC, as an efficient tumor biomarker in gastric cancer. The provided evidence underlines the propitious predictive value of DDC expression in the survival of stomach adenocarcinoma patients.
Similar content being viewed by others
References
Akoh JA, Macintyre IM (1992) Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 79(4):293–299
Avgeris M, Koutalellis G, Fragoulis EG, Scorilas A (2008) Expression analysis and clinical utility of l-Dopa decarboxylase (DDC) in prostate cancer. Clin Biochem 41(14–15):1140–1149. doi:10.1016/j.clinbiochem.2008.04.026
Barranco SC, Townsend CM Jr, Casartelli C, Macik BG, Burger NL, Boerwinkle WR, Gourley WK (1983) Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43(4):1703–1709
Batteiger B, Newhall WJT, Jones RB (1982) The use of Tween 20 as a blocking agent in the immunological detection of proteins transferred to nitrocellulose membranes. J Immunol Methods 55(3):297–307
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713
Cervantes A, Rodriguez Braun E, Perez Fidalgo A, Chirivella Gonzalez I (2007) Molecular biology of gastric cancer. Clin Transl Oncol 9(4):208–215
Chakroborty D, Sarkar C, Mitra RB, Banerjee S, Dasgupta PS, Basu S (2004) Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis. Clin Cancer Res 10(13):4349–4356. doi:10.1158/1078-0432.CCR-04-0059
Chalatsa I, Nikolouzou E, Fragoulis EG, Vassilacopoulou D (2011) l-Dopa decarboxylase expression profile in human cancer cells. Mol Biol Rep 38(2):1005–1011. doi:10.1007/s11033-010-0196-x
Craig SP, Thai AL, Weber M, Craig IW (1992) Localisation of the gene for human aromatic l-amino acid decarboxylase (DDC) to chromosome 7p13→p11 by in situ hybridisation. Cytogenet Cell Genet 61(2):114–116
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581–592. doi:10.1093/annonc/mdl498
Fox JG, Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117(1):60–69. doi:10.1172/JCI30111
Gilbert J, Haber M, Bordow SB, Marshall GM, Norris MD (1999) Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies. Am J Pathol 155(1):17–21
Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362(9380):305–315
Ichinose H, Sumi-Ichinose C, Ohye T, Hagino Y, Fujita K, Nagatsu T (1992) Tissue-specific alternative splicing of the first exon generates two types of mRNAs in human aromatic l-amino acid decarboxylase. Biochemistry 31(46):11546–11550
Isobe K, Nakai T, Yukimasa N, Nanmoku T, Takekoshi K, Nomura F (1998) Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas. Eur J Endocrinol 138(4):383–387
Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI (1990) A comparison of synaptophysin, chromogranin, and l-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res 50(18):6068–6074
Khushalani N (2008) Cancer of the esophagus and stomach. Mayo Clin Proc 83(6):712–722
Kokkinou I, Fragoulis EG, Vassilacopoulou D (2009) The U937 macrophage cell line expresses enzymatically active l-Dopa decarboxylase. J Neuroimmunol 216(1–2):51–58. doi:10.1016/j.jneuroim.2009.09.001
Kontos CK, Papadopoulos IN, Fragoulis EG, Scorilas A (2010) Quantitative expression analysis and prognostic significance of l-DOPA decarboxylase in colorectal adenocarcinoma. Br J Cancer 102(9):1384–1390. doi:10.1038/sj.bjc.6605654
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685
Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408. doi:10.1006/meth.2001.1262
Mappouras DG, Stiakakis J, Fragoulis EG (1990) Purification and characterization of l-dopa decarboxylase from human kidney. Mol Cell Biochem 94(2):147–156
Murakami T (1971) Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 11:53–55
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
Patsis C, Glyka V, Yiotakis I, Fragoulis EG, Scorilas A (2012) l-DOPA decarboxylase (DDC) expression status as a novel molecular tumor marker for diagnostic and prognostic purposes in laryngeal cancer. Transl Oncol 5(4):288–296
Sakakura C, Takemura M, Hagiwara A, Shimomura K, Miyagawa K, Nakashima S, Yoshikawa T, Takagi T, Kin S, Nakase Y, Fujiyama J, Hayasizaki Y, Okazaki Y, Yamagishi H (2004) Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. Br J Cancer 90(3):665–671. doi:10.1038/sj.bjc.6601544
Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12(19):2979–2990
Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T (1992) Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic l-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 31(8):2229–2238
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76(9):4350–4354
Trager C, Vernby A, Kullman A, Ora I, Kogner P, Kagedal B (2008) mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis. Int J Cancer 123(12):2849–2855. doi:10.1002/ijc.23846
Vassilacopoulou D, Sideris DC, Vassiliou AG, Fragoulis EG (2004) Identification and characterization of a novel form of the human l-dopa decarboxylase mRNA. Neurochem Res 29(10):1817–1823
Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R (1993) Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218(5):583–592
Wittekind C, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH (2005) TNM-Atlas, 5th edn. Springer, New York (UICC)
Yasui W, Sentani K, Motoshita J, Nakayama H (2006) Molecular pathobiology of gastric cancer. Scand J Surg 95(4):225–231
Zhu MY, Juorio AV (1995) Aromatic l-amino acid decarboxylase: biological characterization and functional role. Gen Pharmacol 26(4):681–696
Acknowledgments
We thank Bodossaki Foundation for the generous donation of the thermal cycler ABI Prism 7500.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Florou, D., Papadopoulos, I.N., Fragoulis, E.G. et al. l-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas. J Cancer Res Clin Oncol 139, 297–306 (2013). https://doi.org/10.1007/s00432-012-1326-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-012-1326-8